MacroGenics provides update on corporate progress and 1Q 2021 financial results. [2 tables in original article]
| Title: | MacroGenics provides update on corporate progress and 1Q 2021 financial results. [2 tables in original article] |
|---|---|
| Source: | Chemical Business NewsBase (UK), April 29, 2021, 3pp |
| Abstract: | MacroGenics Inc, a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, provided on 29 Apr 2021 an update on its recent corporate progress and reported financial results for the 1Q 2021 ended 31 Mar 2021. Cash, cash equivalents and marketable securities as of 31 Mar 2021, were $343.2 M, compared to $272.5 M as of 31 Dec 2020... |
| Database: | NewsBank |
| Published in: | Chemical Business NewsBase (UK) |
|---|---|
| Language: | English |